healthcareЗдравоохранение. HealthcareHealthcare1027-7218Republican Scientific and Practical Center for Medical Technologies, Informatization, Management and Health Economics10.65249/1027-7218-2026-1-65-73healthcare-243Research ArticleСЛУЧАИ ИЗ КЛИНИЧЕСКОЙ ПРАКТИКИCASES FROM CLINICAL PRACTICEСистемная красная волчанка: разбор клинического случаяSystemic lupus erythematosus: analysis of the clinical casehttps://orcid.org/0000-0002-9915-2965СорокаН. Ф.SorokaN.

Сорока Николай Федорович – д. м. н., профессор, врач-ревматолог, руководитель Республиканского ревматологического центра

Ул. Семашко, 8, 220045, г. Минск

Сл. тел. +375 17 277-27-93

Минский научно-практический центр хирургии, трансплантологии и гематологииBelarus202614022026016573Copyright © Сорока Н.Ф., 20262026Сорока Н.Ф.Soroka N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://healthcare.ejournal.by/jour/article/view/243

Статья посвящена проблеме полиморбидности при системной красной волчанке (СКВ). Подробно описан клинический случай СКВ хронического течения, на определенном этапе болезни протекавший с перипартальной кардиомиопатией и острым повреждением почек. Наличие у пациентки СКВ затрудняло своевременную диагностику сопутствующей патологии, так как развитие перипартальной кардиомиопатии изначально расценивали как волчаночный кардит, а острое повреждение почек гемодинамической и лекарственной природы – как волчаночный нефрит.

The article is devoted to the problem of polymorbidity of systemic lupus erythematosus (SLE). A clinical case of SLE with a chronic course, which at a certain stage of the disease occurred with peripartal cardiomyopathy and acute kidney injury, is described in detail. The presence of SLE in the patient made it difficult to diagnose concomitant pathology timely, since the development of peripartal cardiomyopathy was initially regarded as lupus carditis, as well as acute hemodynamic and medicinal kidney injury as lupus nephritis.

системная красная волчанкаперипартальная кардиомиопатияострое повреждение почек.systemic lupus erythematosusperipartal cardiomyopathyacute kidney injury.ReferencesSiegel, C. H. Systemic lupus erythematosus: a review / C. H. Siegel, L. R. Sammaritano // JAMA. – 2024. – Vol. 331 (17). –P. 1480–1491.Siegel C.H., Sammaritano L.R. Systemic lupus erythematosus. JAMA. 2024; 331(17): 1480–1491.Population-based incidence and prevalence of systemic lupus erythematosus : the Michigan lupus epidemiology and surveillance program / E. C. Somers, W. Marder, P. Cagnoli [et al.] // Arthritis & Rheumatology. – 2014. – Vol. 66 (2). – P. 369–378.Somers E.C., Marder W., Cagnoli P., et al. Population-based incidence and prevalence of systemic lupus erythematosus. Arthritis Rheumatol. 2014; 66(2): 369–378.Overall and cause-specific mortality in patients with systemic lupus erythematosus : a meta-analysis of observational studies / M. Yurkovich, K. Vostretsova, W. J. Chen, J. A. Avina-Zubieta // Arthritis Care & Research. – 2014. – Vol. 66. – P. 608–616.Yurkovich M., Vostretsova K., Chen W.J., Avina-Zubieta J.A. Overall and cause-specific mortality in patients with systemic lupus erythematosus. Arthritis Care Res. 2014; 66: 608–616.Dai, X. Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics / X. Dai, Y. Fan, X. Zhao // Signal Transduction and Targeted Therapy. – 2025. – Vol. 10. – doi: 10.1038/s41392-025-02168-0.Dai X., Fan Y., Zhao X. Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. Signal Transduct Target Ther. 2025; 10. doi: 10.1038/s41392-025-02168-0.Genetic and phenotypic landscape of peripartum cardiomyopathy / R. Goli, J. Li, J. Brandimarto [et al.] // Circulation. – 2021. – Vol. 143 (19). – P. 1852–1862.Goli R., Li J., Brandimarto J., et al. Genetic and phenotypic landscape of peripartum cardiomyopathy. Circulation. 2021; 143(19): 1852–1862.Peripartum cardiomyopathy : JACC state-of-the-art review / N. B. Davis, Z. Arany, D. M. McNamara [et al.] // Journal of the American College of Cardiology. – 2020. – Vol. 75(2). – P. 207–221.Davis N.B., Arany Z., McNamara D.M., et al. Peripartum cardiomyopathy. J Am Coll Cardiol. 2020; 75(2): 207–221.Were pregnant women more affected by COVID-19 in the second wave of the pandemic? / S. Kadiwar, J. J. Smith, S. Ledot [et al.] // Lancet. – 2021. – Vol. 397. – P. 1539–1540.Kadiwar S., Smith J.J., Ledot S., et al. Were pregnant women more affected by COVID-19 in the second wave of the pandemic? Lancet. 2021; 397: 1539–1540.High prevalence of viral genomes and inflammation in peripartum cardiomyopathy / B. D. Bultmann, K. Klingel, M. Nabauer [et al.] // American Journal of Obstetrics & Gynecology. – 2005. – Vol. 193. – P. 363–365.Bultmann B.D., Klingel K., Nabauer M., et al. High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. Am J Obstet Gynecol. 2005; 193: 363–365.ESC Guidelines for the management of cardiovascular diseases during pregnancy / V. Regitz-Zagrosek, J. W. Roos-Hesselink, J. Bauersachs [et al.] // The European Heart Journal. – 2018. – Vol. 39 (34). – P. 3165–3241.Regitz-Zagrosek V., Roos-Hesselink J.W., Bauersachs J., et al. ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018; 39(34): 3165–3241.IPAC investigators. Clinical outcomes for peripartum cardiomyopathy in North America : results of the IPAC study (investigations of pregnancy-associated cardiomyopathy) / D. M. McNamara, U. Elkayam, R. Alharethi [et al.] // Journal of the American College of Cardiology. – 2015. – Vol. 66. – P. 905–914.McNamara D.M., Elkayam U., Alharethi R., et al. IPAC investigators. Clinical outcomes for peripartum cardiomyopathy in North America. J Am Coll Cardiol. 2015; 66: 905–914.Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American women / O. C. Irizarry, L. D. Levine, J. Lewey [et al.] // JAMA Cardiology. – 2017. – Vol. 2. – P. 1256–1260.Irizarry O.C., Levine L.D., Lewey J., et al. Comparison of clinical characteristics and outcomes of peripartum cardiomyopathy between African American and non-African American women. JAMA Cardiol. 2017; 2: 1256–1260.Amos, A. M. Improved outcomes in peripartum cardiomyopathy with contemporary / A. M. Amos, W. A. Jaber, S. D. Russell // American Heart Journal. – 2006. – Vol. 152. – P. 509–513.Amos A.M., Jaber W.A., Russell S.D. Improved outcomes in peripartum cardiomyopathy with contemporary. Am Heart J. 2006; 152: 509–513.

The authors declare that there are no conflicts of interest present.